Global carbenicillin market is expected to grow at a CAGR of 4.0% to 2027

Published Date: April 8, 2021 |

Global carbenicillin market is expected to grow at a CAGR of 4.0% to 2027

Carbenicillin is categorized as a semisynthetic penicillin antibiotic which is widely employed in cell culture and molecular biology application due to its ability to inhibit cell wall synthesis by inactivating the transpeptidase present on the inner cell surface of the microbial cell wall.

Browse the full report Carbenicillin Market – Growth, Future Prospects, Competitive Analysis, 2020 – 2027 report at https://www.researchcorridor.com/carbenicillin-market/

Cell culture is representing the largest market share in the application segment for the carbenicillin market. Ergonomic features such as very high and improved stability in comparison to ampicillin render it to use in a concentration of 100 μg/ml in the cell culture media for a selection of ampr transformed cells. Additionally, features such as high resistance to heat and low pH-induced degradation with respect to different time intervals in the accelerated stability testing studies increase it applicability in liquid culture growth. Molecular biology is going to record rampant market growth during the forecast period on account of the rising prevalence of pandemic infections and chronic diseases worldwide. Carbenicillin is widely used to regulate bacterial growth in the plants thereby yielding low regeneration frequencies and it is also utilized as a gene selection antibiotic in plant molecular biology to utilize the CRISPR / CAS9 system.

Biopharmaceutical companies are presently leading the end-user segment for the carbenicillin market. Severe adverse side effects associated with chemotherapy have resulted in the increasing demand for gene therapy and immunotherapy for the treatment of metastatic cancer owing to its enhanced therapeutic efficacy and safety. Significant increase in the research and development sector of the lifesciences segment for the development of bioengineered molecules utilized in the treatment of rare hereditary diseases. Research academia is expected to register excellent market growth in the near future owing to the increasing funds provided by the government healthcare agencies for novel drug development to curb the mortality rate associated with infectious and chronic diseases across the globe.

North America is presently spearheading the geography segment for the carbenicillin market. The existence of developed healthcare infrastructure and increasing public health awareness regarding therapeutic application of biomolecules in the treatment of chronic diseases together steer the market growth in the region. The presence of major players such as Thermo Fisher Scientific, Santa Cruz Biotechnology, Inc., VWR International, LLC, Selleck Chemicals etc. fortify the carbenicillin market growth in the region. Europe is placed 2nd in the regional segment for the carbenicillin market. A supportive regulatory environment for the sale and distribution of carbenicillin in the Lifesciences industry segment provided by the European Medical Agency (EMA), further accentuates the market growth. The Asia Pacific is anticipated to be the fastest-growing regional segment for the carbenicillin market. The developing Lifesciences industry and the emergence of local manufacturers together determine the carbenicillin market growth in the Asia Pacific region.

To know more about the study, request a report sample

Pharmaceutical manufacturers actively engaged in the production of carbenicillin are Merck KGaA, Thermo Fisher Scientific., Corning, HiMedia Laboratories, VWR International, LLC, Gold Biotechnology, Inc., Selleck Chemicals, Santa Cruz Biotechnology, Inc., Canvax Biotech S.L., and CliniSciences.

Key Market Movements:

  • Increasing demand for cell culture studies to critically analyze the microbial resistance against antibiotics
  • Constant rise in the gene therapy and bioengineered molecules for the treatment of cancer and rare hereditary diseases worldwide
  • Higher preference of carbenicillin in comparison to ampicillin in molecular biology application owing to its high stability and resistance to degradation
Fill the given form to request sample for Global carbenicillin market is expected to grow at a CAGR of 4.0% to 2027 Market Report [contact-form-7 id="143911" title="Request Sample"]
Fill the given form to inquiry before buying for Global carbenicillin market is expected to grow at a CAGR of 4.0% to 2027 Market Report [contact-form-7 id="143909" title="Inquiry Buying"]